All articles tagged with #cold chain
UK NIHR trial shows a dry-powder, trehalose-stabilised tetanus–diphtheria vaccine that can be stored at room temperature and still elicit an equivalent immune response, potentially removing cold-chain needs and reducing wastage; a larger 160-person trial is planned, with potential applicability to other vaccines and some medicines, though not all (e.g., mRNA).
Logistics giants like UPS, FedEx, DHL and others are expanding temperature-controlled capabilities to service a booming healthcare market driven by GLP-1 therapies (e.g., Ozempic/Wegovy, Mounjaro/Zepbound) and other biologics, investing in refrigerated facilities and AI-enabled tracking to ensure end-to-end cold-chain reliability. Demand is projected to grow about 8.3% CAGR to 2033, reaching roughly $39 billion, as companies report rising healthcare revenues and shift toward specialized therapies and patient-focused delivery.
UPS will invest $48 million to upgrade 27 temperature-controlled facilities across its network to bolster end-to-end cold-chain capabilities as demand for temperature-sensitive biologics, including GLP-1 drugs, grows; the move underscores healthcare as a major growth area for UPS and aims to speed and secure delivery of critical medicines globally.